Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Other Non-Current Liabilities: 2011-2019

Historic Other Non-Current Liabilities for EyePoint Pharmaceuticals (EYPT) over the last 1 years, with Mar 2019 value amounting to $2.1 million.

  • EyePoint Pharmaceuticals' Other Non-Current Liabilities fell 69.81% to $2.1 million in Q1 2019 from the same period last year, while for Mar 2019 it was $2.1 million, marking a year-over-year decrease of 69.81%. This contributed to the annual value of $19.8 million for FY2018, which is 38684.31% up from last year.
  • Latest data reveals that EyePoint Pharmaceuticals reported Other Non-Current Liabilities of $2.1 million as of Q1 2019, which was up 44.33% from $1.5 million recorded in Q4 2018.
  • EyePoint Pharmaceuticals' 5-year Other Non-Current Liabilities high stood at $19.8 million for Q2 2018, and its period low was $51,000 during Q2 2017.
  • Its 3-year average for Other Non-Current Liabilities is $5.3 million, with a median of $1.8 million in 2018.
  • Per our database at Business Quant, EyePoint Pharmaceuticals' Other Non-Current Liabilities soared by 38,684.31% in 2018 and then crashed by 69.81% in 2019.
  • Over the past 3 years, EyePoint Pharmaceuticals' Other Non-Current Liabilities (Quarterly) stood at $51,000 in 2017, then surged by 38,684.31% to $1.5 million in 2018, then plummeted by 69.81% to $2.1 million in 2019.
  • Its Other Non-Current Liabilities was $2.1 million in Q1 2019, compared to $1.5 million in Q4 2018 and $1.3 million in Q3 2018.